drugset / Trial / NCT02147262

Laboratory Characteristics in Chronic Atrophic Acrodermatitis

NCT02147262

RandomizedParallel-groupOpen-labelBasic science

Summary

The main objective of this study is to characterize the inflammatory proteins, gene polymorphisms, and transcriptome profiles in patients with chronic atrophic dermatitis to gain better insight into pathogenesis of chronic infection with Borrelia burgdorferi sensu lato.

Timeline

Start
2013-07
Primary completion
2020-07
Completion
2020-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Doxycycline Small molecule 100 mg Oral